An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.


The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug

You May Also Like

‘30 Rock’ actor Will Arnett sells $20.2 million Beverly Hills home to Paris Hilton’s brother-in-law

Will Arnett has sold his Beverly Hills home to none other than Paris Hilton’s brother-in-law just…

Real-estate agents on how they handle haunted homes in an already-scary housing market

This Halloween, real-estate agents reflect on some of the creepiest, spookiest homes…

Nvidia’s stock rises as Trump blesses China sales. Here’s how big the opportunity could be.

Nvidia previously pegged lost China revenue at $8 billion a quarter, and…

Powell faces his most pivotal test yet: Trump pressure, Fed dissent and a sky-high stock market

But this week all eyes will be on Powell as he holds…